Stocks and Investing
Stocks and Investing
Fri, August 2, 2019
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
Thu, August 1, 2019
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
[ Thu, Aug 01st 2019
] - WOPRAI
Paul Matteis Maintained (VRTX) at Strong Buy with Increased Target to $211 on, Aug 1st, 2019
Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $205 to $211 on, Aug 1st, 2019.
Paul, nor any peers, have made any analyst calls on VRTX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Mon, Apr 15th 2019
] - WOPRAI
[ Thu, Mar 07th 2019
] - WOPRAI
[ Thu, Feb 01st 2018
] - WOPRAI
[ Thu, Feb 01st 2018
] - WOPRAI
[ Thu, Dec 01st 2016
] - WOPRAI
[ Mon, Feb 01st 2016
] - WOPRAI
[ Tue, Dec 01st 2015
] - WOPRAI
[ Thu, Aug 01st 2013
] - WOPRAI
[ Wed, Mar 14th 2012
] - WOPRAI